Biovista and Dart Therapeutics partnered to use Biovista's Clinical Outcome Search Space (COSS) technology to identify which of Dart's existing compounds may be used to treat Duchenne muscular dystrophy (DMD)

Biovista Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Dart Therapeutics Inc.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced